标题 |
A phase III trial of adjuvant ribociclib plus endocrine therapy vs endocrine therapy alone in patients with HR+/HER2− early breast cancer: final invasive disease–free survival results from the NATALEE trial
HR+/HER2-早期乳腺癌患者辅助ribociclib联合内分泌治疗与单独内分泌治疗的III期试验:NATALEE试验的最终侵袭性无病生存期结果
|
网址 | |
DOI | |
其它 |
期刊:Annals of Oncology 作者:G.N. Hortobagyi; A. Lacko; J. Sohn; F. Cruz; M. Ruiz Borrego; et al 出版日期:2024 |
求助人 | |
下载 |